Navigation Links
Medgenics Announces Encouraging Preliminary Data For Phase I/II Clinical Trial of EPODURE In Renal Anemia
Date:11/3/2008

gcg.com">lwolf-creutzfeldt@hfgcg.com

Grayling Global, Media Relations Phone: +1 646 284 9455

Ivette Almeida ialmeida@hfgcg.com

ABOUT MEDGENICS:

Medgenics, Inc. is a clinical-stage biopharmaceutical company developing its unique tissue-based Biopump platform technology to provide sustained-action protein therapy for the treatment of a range of chronic diseases.

Medgenics currently has two products in development based on this technology:

-- EPODURE -- producing erythropoietin (EPO) to treat anaemia

-- INFRADURE -- producing interferon-alpha (IFN-a) to treat hepatitis C

The Company has demonstrated proof of principle of the Biopump treatment procedure in a clinical trial using a short-acting version of EPODURE in anemic subjects. The Company commenced a Phase I/II clinical trial for its long-acting version of EPODURE, designed to produce and deliver a therapeutic dose of EPO steadily for three to six months or more, in August 2008. The Company plans to follow with a clinical trial of INFRADURE in 2009.

Medgenics intends to develop its innovative products and bring them to market via multiple strategic partnerships with major pharmaceutical and/or medical device companies, starting with EPODURE and INFRADURE.

Beyond these, Medgenics plans to develop and/or out-license a pipeline of future Biopump products targeting the large and rapidly growing global protein therapy market, which is forecast to reach US $87 billion by 2010. Other potential areas include multiple sclerosis (interferon-ß), haemophilia (Factor XIII), paediatric growth hormone deficiency (human growth hormone) and diabetes (insulin).

Founded in 2000, Medgenics is a US-incorporated company with major operations in Misgav, Israel. Medgenics was admitted to AIM in December 2007 (AIM: MEDG).

http://www.medg
'/>"/>

SOURCE Medgenics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Cambridge Semantics, the leading provider of Smart ... in the recent ‘Hype Cycle for Life Sciences 2014 ... details key insights pertaining to the benefits in the ... Michael Shanler and Stephen Davies, “The use of these ... with scientific stakeholders, and support collaboration and innovation strategies ...
(Date:9/23/2014)... 23, 2014 Dr. Williams says, “Find ... on healthcare offers a three phase process that can ... delivery system that would go far beyond anything previously ... the delivery of healthcare.” , “Every effort to improve ... to provide discernable progress throughout that system because all ...
(Date:9/22/2014)... September 22, 2014 Pearl's Premium Ultra ... in drought tolerant grass seed this week with the ... The announcement coincides with the fact that it is ... as many believe. , As of the date ... favorable reviews by industry experts and the media including: ...
(Date:9/22/2014)... in a mouse model of pancreatic cancer identified distinct ... including significant differences from the primary tumor that may ... their study reported in the Sept. 25 issue of ... Hospital (MGH) Cancer Center identified several different classes of ... to be targets for improved treatment of the deadly ...
Breaking Biology Technology:Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2Pearl's Premium Ultra Low Maintenance Lawn Seed Announces A Major Breakthrough In Drought Tolerant Grass Seed 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 3
... Calif., Feb. 6 Onyx,Pharmaceuticals, Inc. (Nasdaq: ... the BIO CEO & Investor Conference on Wednesday, ... may access a live webcast of the,presentation at:, ... log on 15 minutes early in order to,register ...
... Avatar Software Platform Further Solidifies Netsmart as Leader in Behavioral ... ... Florida, GREAT RIVER, N.Y., Feb. 6 Netsmart Technologies, ... services organizations, today announced it has signed a contract to,provide comprehensive ...
... Global Probiotics Council,(GPC), a committee established in 2004 ... the Young Investigator Grant for probiotics research,program (YIGPRO) ... stimulate,innovative research and to support young investigators and ... field of probiotics and gut,microbiota., "Our two ...
Cached Biology Technology:Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 2Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 3Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 2Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 4
(Date:9/23/2014)... Ill. Antarctic fishes that manufacture their own ... Ocean also suffer an unfortunate side effect, researchers ... their bodies resist melting even when temperatures warm. ... Proceedings of the National Academy of Sciences ... an undesirable consequence of the evolution of antifreeze ...
(Date:9/23/2014)... has domesticated animals, selecting the best traits possible ... an intriguing animal to examine adaptation to climate ... selected breeding and a wealth of livestock genome-wide ... study that combined molecular and environmental data, professor ... genes under environmental selection from domesticated sheep breeds. ...
(Date:9/23/2014)... successful rise and fall of an athlete,s moving body relies ... putting the many angles and intersecting planes literally the ... to the test. But it,s more than just a footfall ... of sports injuries: the ACL or anterior cruciate ligament tear. ... at the center of the knee joint and volume ...
Breaking Biology News(10 mins):Study: Antifreeze proteins in Antarctic fishes prevent freezing ... and melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezing ... and melting 3Being sheepish about climate adaptation 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 3
... in 100 inhabitants died from Spanish flu in 1918, but ... An important explanation for the differences is due to different ... came. Those living in urban communities probably had a higher ... in 1918 than those living in very isolated rural areas. ...
... other businesses step up efforts to cut waste, reduce ... products and processes, the number of planet-friendly standards and ... a sometimes-confusing array of options for "going green." National ... a framework to help organizations of all types sort ...
... Article highlights from the May issue of The American Naturalist ... a second, Genes control fruit flies, social groupings, What can twins ... issue table of contents, go to www.journals.uchicago.edu/an . ... kstacey@press.uchicago.edu . Cuttlefish: From camo to tuxedo ...
Cached Biology News:Large differences in mortality between urban and isolated rural areas 2Large differences in mortality between urban and isolated rural areas 3NIST prototypes framework for evaluating sustainability standards 2Tipsheet for the May issue of the American Naturalist 2Tipsheet for the May issue of the American Naturalist 3
Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human peripheral blood CD14+ monocytes, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Human endothelial progenitor cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Yeast tRNA 50 l...
Biology Products: